Deborah Pulaski
Investor Relations
Replay available
Astronics Corporation (NASDAQ: ATRO) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.

Investor Relations
Chairman, President & CEO
Chief Financial Officer
CJS Securities
Analyst, Truist Securities
Greetings and welcome to the Astronics Corporation first quarter fiscal year 2025 financial results conference call. At this time, all participants are in listen-only mode. If anyone should require operator assistance, please press star zero on your telephone keypad. A question and answer session will follow the formal presentation. You may be placed into question queue at any time by pressing star one on your telephone keypad. As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to your host, Deborah Pulaski, Investor Relations for Astronics Corporation. Please go ahead, Deb. Thanks, Kevin, and good afternoon, everyone. We certainly appreciate your time today and your interest in astronomy. On the call with me here, I have Pete Gunderman, our Chairman and President CEO, and Nancy Hedges, our Chief Financial Officer. You should have a copy of our first quarter results, which crossed the wires after the market closed today. And if you don't have that release, you can find it on our website at astronics.com. As you are aware, we may make some forward-looking statements during the formal discussion and the Q&A session of this conference call. These statements apply to future events that are subject to risks and uncertainties, as well as other factors that could cause actual results to differ materially from what is stated here today. These risks and uncertainties and other factors are provided in the earnings release as well as with other documents filed with Securities and Exchange Commission. You can find those documents on our website or at sec.gov. During today's call, we'll also discuss some non-GAAP measures, which we believe will be useful in evaluating our performance. We should not consider the presentation of this additi...